Xyrem
Ended Awarded Last action
- Contract number
- 36C26124N0592
- Awardee
-
Jazz Pharmaceuticals, Inc. UEI H9AXCNRA5NE6
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- -$9,186
Award facts
- Contract value 0% obligated
- $25,574.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Palo Alto, CA 94304, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$9,186 | |
| Original award | $34,760 |
About this award
Jazz Pharmaceuticals, Inc. received a delivery order award valued at $25,574.10 from Veterans Integrated Service Network 21, a civilian component of the Department of Veterans Affairs, on April 16, 2024, with an ultimate completion date of July 16, 2024. This firm fixed-price delivery order is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and covers XYREM (sodium oxybate), a specialty pharmaceutical indicated for treating narcolepsy and sleep disorders in veteran populations. The award was made on an unrestricted, competitive basis with no set-aside designation applied. Performance will occur in Palo Alto, California, where Jazz Pharmaceuticals maintains its headquarters and primary operations for federal pharmaceutical distribution.
This delivery order is part of Jazz Pharmaceuticals' broader relationship with the VA through a single-award Blanket Purchase Agreement valued at $161.2 billion, established under the same Federal Supply Schedule and authorized through August 2026. Jazz Pharmaceuticals serves as the prime contractor with no identified subcontractors, and has demonstrated sustained federal contracting activity spanning multiple years and Veterans Integrated Service Networks. The BPA structure enables the VA to efficiently procure critical sleep disorder medications across its medical facilities nationwide while maintaining pricing stability, supporting the department's mission to deliver specialized healthcare services to veterans.
Quick answers
Who was awarded contract 36C26124N0592?
36C26124N0592 was awarded to Jazz Pharmaceuticals, Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on April 16, 2024.
How much is contract 36C26124N0592 worth?
The government has obligated -$9,186 on 36C26124N0592. Its current value, with exercised options, is $25,574.
Is contract 36C26124N0592 an order under another contract?
Yes. 36C26124N0592 is a delivery order under 36F79719D0205, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26124N0592 competed?
The extent of competition for 36C26124N0592 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award